Clinical Trial Update: The Formulation of Compound Phellinus Igniarius Decoction on Radiation Pneumonitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the formulation of Compound Phellinus Igniarius Decoction for radiation pneumonitis. The study was sponsored by Zhejiang Cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Pneumonitis

Drugs mentioned

• Compound Phellinus Igniarius Decoction (Phellinus igniarius decoction)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Radiation Pneumonitis | Phase 1 | Status: COMPLETED